Cover Image

Proton Pump Inhibitors and Gastric Cancer

Concerns have been raised regarding the long-term use of proton pump inhibitors (PPIs) as an important risk factor for gastric cancer in clinical practice. PPIs can cause hypergastrinemia at clinical doses, and hypergastrinemia has been reported to induce malignant neoplasms in the stomach in previo...

Full description

Saved in:

Bibliographic Details
Main Authors:	Seungkyung Kang (Author), Soo-Jeong Cho (Author)
Format:	Book
Published:	Yong Chan Lee, 2021-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Proton pump inhibitors usage and the risk of cancer
by: Hubert Wróblewski, et al.
Published: (2021)

Clinicians should be aware of proton pump inhibitor-related changes in the gastric mucosa
by: Gwang Ha Kim
Published: (2024)

Proton Pump Inhibitors and Cancer: Current State of Play
by: Marie Bridoux, et al.
Published: (2022)

Peculiarities of pathogenesis of gastric cancer formed in the treatment of chronic non-atrophic gastritis by proton pump inhibitors
by: A. A. Avramenko, et al.
Published: (2018)

Peculiarities of pathogenesis of gastric cancer formed in the treatment of chronic non-atrophic gastritis by proton pump inhibitors
by: A. A. Avramenko, et al.
Published: (2018)

Association of proton pump inhibitors with gastric and colorectal cancer risk: A systematic review and meta-analysis
by: Huizhu Guo, et al.
Published: (2023)

Proton pump inhibitors in pediatric practice
by: Anna A. Shilova, et al.
Published: (2023)

RENAL SAFETY OF PROTON PUMP INHIBITORS
by: A. I. Dyadyk, et al.
Published: (2017)

Can proton pump inhibitors cause intestinal inflammation in children?
by: Ben Kang
Published: (2019)

Risk of Bacterial Infection from Proton Pump Inhibitor Use
by: Sung Soo Kim, et al.
Published: (2017)

Impact of a Restriction in Reimbursement on Proton Pump Inhibitors in Patients with an Increased Risk of Gastric Complications
by: Linda E. Flinterman, et al.
Published: (2018)

Management of laryngopharyngeal reflux with proton pump inhibitors
by: Christina Reimer, et al.
Published: (2008)

Proton-pump inhibitors and risk of renal disease
by: Mahrang Hedaiaty, et al.
Published: (2017)

Proton Pump Inhibitors in the COVID-19 Pandemic
by: T. E. Kugler, et al.
Published: (2022)

Is hypomagnesemia associated with using proton pump inhibitors?
by: Joo-Hark Yi, et al.
Published: (2016)

Proton pump inhibitors overuse - consequences among patients
by: Patrycja Kmiotek, et al.
Published: (2019)

Proton pump inhibitors overuse - consequences among patients
by: Patrycja Kmiotek, et al.
Published: (2019)

The consequences of long-term therapy with proton pump inhibitors
by: Zuzanna Drygała, et al.
Published: (2024)

Exploring and understanding adverse effect of Proton Pump Inhibitors
by: Hoque Majedul M.
Published: (2024)

Can Proton Pump Inhibitors Affect Eradication Therapy?
by: Sung Eun Kim
Published: (2020)

Proton Pump Inhibitor Long-term Prescription, Is It Safe?
by: Tae Ho Kim
Published: (2020)

Proton pump inhibitor deprescription: A rapid review
by: Renata Rodriguez Imparato, et al.
Published: (2022)

The Impact of Sex on the Response to Proton Pump Inhibitor Treatment
by: Holmfridur Helgadottir, et al.
Published: (2023)

An unusual case of proton pump inhibitor induced hyperchromograninemia
by: Kwabena Oware Adu-Gyamfi, et al.
Published: (2019)

Gastric Corpus Hypertrophy with a Bleeding Hyperplastic Polyp in a -naive Subject after Long-term Proton Pump Inhibitor Use
by: Jong Hyeon Jeong, et al.
Published: (2022)

Non-specific gastric inflammation in children is associated with proton pump inhibitor treatment for more than 6 weeks
by: Eduardo Daniel Rosas-Blum, et al.
Published: (2014)

Association between occurrence of multiple white and flat elevated gastric lesions and oral proton pump inhibitor intake
by: Rino Hasegawa, et al.
Published: (2024)

Drug Repositioning of Proton Pump Inhibitors for Enhanced Efficacy and Safety of Cancer Chemotherapy
by: Kenji Ikemura, et al.
Published: (2017)

The Effect of Proton Pump Inhibitors on Fracture Formation and Reflection on Care
by: Seda Akutay, et al.
Published: (2021)

Analysis of the Effect of Proton-Pump Inhibitors on the Course of COVID-19
by: Zhang XY, et al.
Published: (2021)

Association between proton pump inhibitors and periodontal disease severity
by: Bhavneet K. Chawla, et al.
Published: (2022)

Proton Pump Inhibitors in IPF: A Call for Clinical Trials
by: Yohannes T. Ghebre, et al.
Published: (2018)

Proton-pump inhibitor use amongst patients with severe hypomagnesemia
by: Sherry Seah, et al.
Published: (2023)

Antiplatelet agents and proton pump inhibitors – personalizing treatment
by: Eugene Lin, et al.
Published: (2010)

Are Proton Pump Inhibitors Contributing in Emerging New Hypertensive Population?
by: Rohit Tayal, et al.
Published: (2023)

Proton pump inhibitors to control phosphorus levels in hemodialysis patients
by: Amineh Hojati
Published: (2025)

The Role of Proton Pump Inhibitors in the Management of Pediatric Eosinophilic Esophagitis
by: Carolina Gutiérrez-Junquera, et al.
Published: (2018)

Irrational proton pump inhibitor use during corticosteroid therapy
by: Rakesh Agarwal, et al.
Published: (2018)

Association of proton pump inhibitor use with renal outcomes in patients with coronary artery disease
by: Nam-Jun Cho, et al.
Published: (2018)

Current Physician's Perception of Proton Pump Inhibitor-related Adverse Effects
by: Cheol Woong Choi
Published: (2021)